Publications by authors named "C V Filip"

Professional medical care in the case of diabetes is of utmost importance to ensure patient health, compliance, and comfort. In the past decades, the emergence of healthcare medical devices has also brought important advancements in diabetology. However, this also raised new provocations for patients and healthcare professionals as well, regarding the acceptance, use, and contentment of sensors and pumps in the everyday lives of diabetic patients.

View Article and Find Full Text PDF

Central venous catheterization is, now, one of the most routinely used procedures in the NICUs, helping during the care of very sick infants. Pericardial effusion is a very rare but severe complication, with a high mortality. The cases described are part of an ongoing retrospective study where the use of central catheters inserted in our surgical NICU, and its complications is being analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • * A case of a 25-year-old pregnant woman highlighted the importance of cardiac evaluation after foetal bradycardia was detected; she was diagnosed with LQTS type 1, and managed with medication and monitoring, resulting in a safe delivery.
  • * Early detection of foetal heart rate irregularities is critical in pregnancies, as persistent low heart rates can indicate LQTS and may require careful management strategies to ensure
View Article and Find Full Text PDF

(1) The three factors within the Virchow triad play the leading role in the development of deep vein thrombosis (DVT) during pregnancy. (2) This research approaches the various risk factors associated with DVT and its most representative complications, pulmonary thromboembolism and cerebral venous thrombosis, in pregnant and postpartum women across a 15-year period (2007-2021). (3) A total of 201 out of 287 patients with DVT had associated risk factors, while 86 did not present with any.

View Article and Find Full Text PDF

Meldonium is a substance with known anti-anginal effects demonstrated by numerous studies and human clinical trials; however, it does not possess marketing authorization within the European Union, only in ex-Soviet republics. Since 2016, meldonium has been included by the World Anti-doping Agency (WADA) on the S4 list of metabolic modulators. In performance athletes, meldonium is now considered a doping agent due to its capacity to decrease lactate production during and after exercise, its capability to enhance the storage and utilization of glycogen, and its protective action against oxidative stress.

View Article and Find Full Text PDF